We are a speciality chemical manufacturer who, through the imaginative and practical use of science, creates ingredients and technologies that improve people’s lives by enhancing everyday products.

Read more about Croda

Investor Centre

Financial Highlights 2014

Revenue

£1046.6m
(2013: £1,077.0m)

Adjusted Operating Profit

£248.4m
(2013: £264.6m)

Dividend per share

65.5p
(2013: 64.5p)

NPP sales as a % of Group sales

23.4%
(2013: 21.4%)

Croda’s Insights into “Bioavailability in the Skin” Shared at Metropolitan University of Mexico Event

June 2015: Croda recently presented a lecture on “Bioavailability in The Skin” to 120 attendees at the Metropolitan University of Mexico...read the full article

Croda Appoint Head of Investor Relations

Conleth Campbell has been formally appointed as Vice President Investor Relations and Corporate Finance for Croda International plc...read the full article